Publication | Closed Access

A novel recurrent CHEK2 Y390C mutation identified in high-risk Chinese breast cancer patients impairs its activity and is associated with increased breast cancer risk

Breast OncologyOncologyCancer EpidemiologyCancer RiskMedicinePathologyCancer GenomicsBreast CancerCancer GeneticsCancer BiologyRadiation OncologyCancer Research